Longeveron Inc. Common Stock

LGVNNASDAQ • USD
ThemeLongevity & Aging›Age-Related Therapeutics
0.64 USD
↗ 0.00 (0.11%)🟢PRE MARKET (AS OF 04:02 AM EDT)
🟢Market: OPEN

LGVN is currently priced at $0.64. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bullish Golden Cross on the moving averages. LGVN is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Jul 15, 2026.

Open?$0.64
High?$0.64
Low?$0.64
Prev. Close?$0.64
Volume?334
Avg. Volume?263.2K
VWAP?$0.64
Rel. Volume?0.00x
Bid / Ask
Bid?$0.54 × 100
Ask?$0.78 × 100
Spread?$0.25
Midpoint?$0.66
Valuation & Ratios
Market Cap?20.2M
Shares Out?30.1M
Float?27.7M
Float %?92.0%
P/E Ratio?N/A
P/B Ratio?1.26
EPS?-$0.71
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.
Themes
Longevity & Aging›Age-Related TherapeuticsHealthcare - Genomics & Precision Medicine›Gene Therapy & Gene Editing
Employees
38
Market Cap
19.7M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.longeveron.com
Listed
2021-02-12
Address
1951 NW 7TH AVENUE
MIAMI, FL 33136
Phone: 305-302-7158
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
0
Momentum?
50
Short Sent.?
64
Piotroski F-Score?1/9Weak
Altman Z-Score?-9.50Distress
Confidence?52%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?5.74%Elevated
Short Interest?1.6M
Days to Cover?5.9
Free Float27.7M
Avg Daily Volume272.1K
Settlement Date2026-06-30
Financial Health
Current Ratio?3.88Strong
Quick Ratio?3.88Strong
Cash Ratio?3.63Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
75/100
P/E?
N/A▾
P/B?
Peers
100
S&P
92
1.26CHEAP▾
P/S?
Peers
100
S&P
3
16.63HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.2CHEAP▾
EV/Sales?
Peers
100
S&P
51
3.67FAIR▾
Returns & Efficiency
ROE?
S&P
3
-140.0%WEAK▾
ROA?
S&P
3
-105.8%WEAK▾
Cash Flow & Enterprise
FCF?$-18536000
Enterprise Value?$4.5M
Fundamentals ratios updated end of day
MarketsMoversWatchlist